Dr. Phillips is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
520 E 70th St
# Starr
New York, NY 10021Phone+1 212-746-6321Fax+1 212-746-6678
Education & Training
New York Presbyterian Hospital (Columbia Campus)Fellowship, Hematology and Medical Oncology, 2004 - 2007- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2001 - 2004
The Warren Alpert Medical School of Brown UniversityClass of 2001
Certifications & Licensure
NY State Medical License 2003 - 2026
NJ State Medical License 2023 - 2025
Clinical Trials
- Lenalidomide in HTLV-1 Adult T-Cell Leukemia Start of enrollment: 2010 Dec 01
- KW-0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL) Start of enrollment: 2012 Jun 01
Publications & Presentations
PubMed
- 4 citationsXPO1 Enables Adaptive Regulation of mRNA Export Required for Genotoxic Stress Tolerance in Cancer Cells.Rossella Marullo, Sarah C Rutherford, Maria V Revuelta, Nahuel Zamponi, Biljana Culjkovic-Kraljacic
Cancer Research. 2024-01-02 - Deposition of complement components C5b-9 and MASP2 in tissues is not a feature of GVHD and may assist in discriminating GVHD from thrombotic microangiopathy following...Mohammad Alhomoud, Cynthia Magro, Surya Seshan, Taotao Zhang, Alexandra Gomez-Arteaga
Bone Marrow Transplantation. 2023-11-01 - 11 citationsASTCT Clinical Practice Recommendations for Transplantation and Cellular Therapies in Diffuse Large B Cell Lymphoma.Narendranath Epperla, Ambuj Kumar, Syed A Abutalib, Farrukh T Awan, Yi-Bin Chen
Transplantation and Cellular Therapy. 2023-09-01
Abstracts/Posters
- Disease Risk Index (DRI) and Age but Not HCT Comorbidity Index (HCT-CI) Are Predictive of Overall Survival after Cord Blood Transplantation Supported By Haplo-CD34+ pr...Adrienne A. Phillips, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Haplo-Cord Transplantation with Anti-Thymocyte Globulin: Comparative Clinical Outcomes with or without Routine G-CSF AdministrationAdrienne A. Phillips, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Thirty-Day Transfusion and G-CSF Requirement after CD19 CAR T InfusionAdrienne A. Phillips, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Hematopoietic Stem Cell Transplant in Novel Agent Era Is Associated with Improved Survival in Relapsed and Refractory Peripheral T-Cell Lymphoma2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Does Presence of Persistent Molecular Mutations Matter in AML Patients Undergoing Allogeneic Stem Cell Transplant?2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- CCR5 delta32 Cord & Haploidentical Grafts: Allogeneic Stem Cell Transplant for HIV+ /AML Patient: A Case Report from the Impaact P1107 Observational StudyClinically Re...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
4 Health Problems African-American Women FaceFebruary 8th, 2018
Expert Sheds Light on Lesser-Known T-cell Lymphoma SubtypesJune 22nd, 2017
Mogamulizumab Offers Option for Rare Relapsed, Refractory T-cell Leukemia/LymphomaJune 23rd, 2016- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
